GBM CSCs-IN-1 (Compound (-)-20), a derivative of rocaglate, is a potent inhibitor of glioblastoma stem cells (GBM CSCs) with an EC50 of 45 nM, functioning by targeting the RNA helicase DDX3. Furthermore, GBM CSCs-IN-1 is also capable of inducing apoptosi
Molecular Weight:
633.51
Formula:
C28H29BrN2O8S
Target:
Apoptosis
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
